Opinion|Videos|June 5, 2024
An Overview of Potential Treatment Adverse Effects
An expert on chronic lymphocytic leukemia discusses adverse effects encountered by patients who are receiving BTK inhibitors or venetoclax-based regimens.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- What types of adverse effects may patients encounter with BTK inhibitor therapy? Venetoclax?
- How are these adverse effects typically managed and how does a multidisciplinary team contribute to this process?
- What guidance do you offer to patients to assist them in effective management of potential adverse events?
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch
2
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You
3
FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer
4
T-Cell Therapies Offer New Ways to Treat Lung Cancer
5